Skip to main content
Clinical Trials/ACTRN12608000149369
ACTRN12608000149369
Recruiting
未知

Evaluation of efficacy and safety of ear-acupressure in treating adult patients with allergic rhinitis: A multi-centre, randomised, sham-controlled clinical trial (EAAR)

Charlie Xue0 sites232 target enrollmentMarch 28, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Allergic Rhinitis
Sponsor
Charlie Xue
Enrollment
232
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Charlie Xue

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 and 70 years (inclusive); history of at least two years of typical symptoms of AR; positive skin prick test to one or more of the following allergens: Seven\-grass mix, Perennial Rye, Ragweed, House mite, Animal’s dander or Mould (RMIT site), or positive serum specific IgE test (GPHCM site); currently not involved in other clinical trials for the treatment of AR; agree to make themselves available for the period of the study; and provide written consent for participation.

Exclusion Criteria

  • Current with systematic corticosteroid therapy; other current active respiratory disease such as asthma; nasal polyposis; other structural defects of the upper respiratory tract; wearing a hearing aid; have a history of being allergic to adhesive tape; history of HIV, Hepatitis B or C; pregnancy; used ear\-acupressure for respiratory diseases within the last six months; or do not read or understand English (RMIT site).

Outcomes

Primary Outcomes

Not specified

Similar Trials